Literature DB >> 12225474

Dynamic susceptibility contrast-enhanced echo-planar imaging of cerebral gliomas. Effect of contrast medium extravasation.

M Essig1, F Wenz, R Scholdei, R Brüning, C Berchtenbreiter, M Meurer, M V Knopp.   

Abstract

PURPOSE: To assess the influence of the degree of contrast medium extravasation on different DSC EPI MR sequences for perfusion MR imaging.
MATERIAL AND METHODS: 60 patients with cerebral gliomas were examined by either an FID EPI or an SE EPI DSC MR sequence. The acquired images were evaluated on a qualitative and quantitative basis. For qualitative assessment, the homogeneity of the signal time curve, image artifacts, the degree of signal drop and the degree of enhancement were evaluated. The quantitative assessment included the percentage of signal drop and the contrast-to-noise ratio of the different EPI sequences was analyzed.
RESULTS: FID EPI presented a more homogeneous signal time curve and a more pronounced susceptibility effect than the SE EPI sequence. Due to the lesser susceptibility effect, the SE EPI sequence was not as sensitive to contrast media extravasation. The signal returned to baseline in all patients. In patients with strongly enhancing lesions, the FID EPI sequence suffered from considerable T1 effects, causing problems in the quantification of perfusion data.
CONCLUSION: FID EPI sequences were preferred for perfusion MR imaging in patients without strong enhancing lesions, e.g. in ischemia or tumors with intact blood-brain barrier. In patients with suspected strong enhancing lesions, an SE EPI sequence should be used.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225474     DOI: 10.1080/j.1600-0455.2002.430402.x

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  11 in total

Review 1.  Clinical experience with MultiHance in CNS imaging.

Authors:  M Essig
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

Review 2.  Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability.

Authors:  Hidemasa Uematsu; Masayuki Maeda
Journal:  Eur Radiol       Date:  2005-06-14       Impact factor: 5.315

3.  Evaluation of contrast agent dose and diffusion coefficient measurement on vessel size index estimation.

Authors:  Behrouz Vejdani Afkham; Sadegh Masjoodi; Mohammad Ali Oghabian; Seyed Roholah Ghodsi; Mohammad Reza Nazem Zadeh; Ebrahim Esmati; Mostafa Farzin; Maziar Gilasi; Hasan Hashemi
Journal:  MAGMA       Date:  2019-07-03       Impact factor: 2.310

Review 4.  Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.

Authors:  David A Reardon; Patrick Y Wen; Annick Desjardins; Tracy T Batchelor; James J Vredenburgh
Journal:  Expert Opin Biol Ther       Date:  2008-04       Impact factor: 4.388

5.  Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging.

Authors:  Hanna Järnum; Elena G Steffensen; Linda Knutsson; Ernst-Torben Fründ; Carsten Wiberg Simonsen; Søren Lundbye-Christensen; Ajit Shankaranarayanan; David C Alsop; Finn Taagehøj Jensen; Elna-Marie Larsson
Journal:  Neuroradiology       Date:  2009-10-20       Impact factor: 2.804

Review 6.  [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].

Authors:  M-A Weber; F Risse; F L Giesel; L R Schad; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

7.  A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract.

Authors:  Sotirios Bisdas; Leon Medov; Mehran Baghi; George N Konstantinou; Jens Wagenblast; Choon Hua Thng; Thomas J Vogl; Tong San Koh
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

8.  Magnetic resonance imaging biomarkers for clinical routine assessment of microvascular architecture in glioma.

Authors:  Andreas Stadlbauer; Max Zimmermann; Gertraud Heinz; Stefan Oberndorfer; Arnd Doerfler; Michael Buchfelder; Karl Rössler
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

Review 9.  The emerging role of anti-angiogenic therapy for malignant glioma.

Authors:  David A Reardon; Annick Desjardins; Jeremy N Rich; James J Vredenburgh
Journal:  Curr Treat Options Oncol       Date:  2008-02-07

10.  Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy.

Authors:  Andreas Stadlbauer; Max Zimmermann; Stefan Oberndorfer; Arnd Doerfler; Michael Buchfelder; Gertraud Heinz; Karl Roessler
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.